| Line item | 2025-11-30 FY | 2024-11-30 FY | 2023-11-30 FY | 2022-11-30 FY | 2021-11-30 FY |
|---|---|---|---|---|---|
| Revenue | $6.84B | $6.72B | $6.66B | $6.35B | $6.32B |
| Cost of Revenue | $4.25B | $4.13B | $4.16B | $4.08B | $3.82B |
| Gross Profit | $2.59B | $2.59B | $2.50B | $2.27B | $2.49B |
| Operating Expenses | – | – | – | – | – |
| R&D | $106.10M | $102.90M | $94.90M | $87.50M | $87.30M |
| SG&A | $1.50B | $1.52B | $1.48B | $1.36B | $1.40B |
| Operating Income | $1.07B | $1.06B | $963.00M | $863.60M | $1.02B |
| Interest Expense | $196.20M | $209.40M | $208.20M | $149.10M | $136.60M |
| Tax Expense | $195.80M | $184.00M | $174.50M | $168.60M | $192.70M |
| Net Income | $789.40M | $788.50M | $680.60M | $682.00M | $755.30M |
| EPS (basic) | 2.9400 | 2.9400 | 2.5400 | 2.5400 | 2.8300 |
| EPS (diluted) | 2.9300 | 2.9200 | 2.5200 | 2.5200 | 2.8000 |
| Shares (diluted) | $269.40M | $269.60M | $269.80M | $270.20M | $269.90M |